Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David McConkey

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Iscience|June 24, 2022
The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Scientific Reports|January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive BehaviorAaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience|July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal for Immunotherapy of Cancer|May 22, 2021
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomesJohn A Ligon, Woonyoung Choi, Gady Cojocaru, et al.
Cell Reports|May 9, 2019
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerCharles C Guo, Tadeusz Majewski, Li Zhang, et al.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 17, 2018
A Festschrift in Honor of Edward M. Messing, MD, FACSJean V Joseph, Ralph Brasacchio, Chunkit Fung, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Iscience|June 24, 2022
The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Scientific Reports|January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive BehaviorAaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience|July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal for Immunotherapy of Cancer|May 22, 2021
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomesJohn A Ligon, Woonyoung Choi, Gady Cojocaru, et al.
Cell Reports|May 9, 2019
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerCharles C Guo, Tadeusz Majewski, Li Zhang, et al.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 17, 2018
A Festschrift in Honor of Edward M. Messing, MD, FACSJean V Joseph, Ralph Brasacchio, Chunkit Fung, et al.
Pageof 8